FESTI, GIULIANA
 Distribuzione geografica
Continente #
NA - Nord America 152
AS - Asia 143
EU - Europa 114
SA - Sud America 20
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 435
Nazione #
US - Stati Uniti d'America 149
SG - Singapore 67
CN - Cina 40
DE - Germania 21
HK - Hong Kong 21
IT - Italia 20
BR - Brasile 18
RU - Federazione Russa 17
FR - Francia 13
SE - Svezia 13
IE - Irlanda 12
GB - Regno Unito 6
KR - Corea 6
FI - Finlandia 5
AT - Austria 3
IN - India 3
BE - Belgio 2
CA - Canada 2
MA - Marocco 2
TG - Togo 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
CO - Colombia 1
JP - Giappone 1
KE - Kenya 1
MX - Messico 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 435
Città #
Singapore 35
Chandler 28
Hong Kong 20
Dallas 16
New York 13
Dublin 12
Ashburn 9
Beijing 9
Jacksonville 6
Munich 6
Southend 6
Bologna 5
Lawrence 5
Princeton 5
Frankfurt am Main 4
Sindelfingen 4
Verona 4
Ann Arbor 3
Guangzhou 3
Hebei 3
Jinan 3
Nanjing 3
Nuremberg 3
Shenyang 3
Turku 3
Wilmington 3
Bari 2
Brussels 2
Delhi 2
Lomé 2
Ningbo 2
Redmond 2
Santa Clara 2
Seattle 2
Vancouver 2
Anapa 1
Aracruz 1
Belo Horizonte 1
Brooklyn 1
Buzău 1
Camaçari 1
Central 1
Charlotte 1
Chennai 1
Chicago 1
Colorado 1
Columbus 1
Cruz Alta 1
Curitiba 1
Fes 1
Formigueiro 1
Fuzhou 1
Haikou 1
Hamanocho 1
Hangzhou 1
Helsinki 1
Itajaí 1
Jundiaí 1
Kent 1
Lahore 1
Lancaster 1
Lappeenranta 1
Las Vegas 1
Los Angeles 1
Macaé 1
Manassas 1
Manila 1
McKenzie 1
Meknes 1
Mercês 1
Milan 1
Nairobi 1
Natal 1
Norwalk 1
Petrolândia 1
Quận Ninh Kiều 1
Redwood City 1
Rio de Janeiro 1
Riohacha 1
Rome 1
Saltillo 1
San Diego 1
San Fernando 1
São Bernardo do Campo 1
São Gabriel da Palha 1
Tashkent 1
Thái Nguyên 1
Tianjin 1
Viamão 1
Vienna 1
Zhengzhou 1
Totale 288
Nome #
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response 81
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 76
Relevance of TH2 markers in the assessment and therapeutic management of severe allergic asthma: A real-life perspective 68
Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy 66
One-year mepolizumab for Allergic bronchopulmonary aspergillosis: Focus on steroid sparing effect and markers of response 61
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 52
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 43
Totale 447
Categoria #
all - tutte 2.365
article - articoli 2.365
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 7 7 2 0 0 0 0 2 0
2021/202243 11 11 1 5 0 0 1 2 2 2 1 7
2022/202393 8 5 12 8 11 19 3 4 17 1 3 2
2023/202451 4 4 4 6 3 14 4 1 1 0 9 1
2024/2025161 18 8 9 16 7 5 6 8 27 8 16 33
2025/202657 34 23 0 0 0 0 0 0 0 0 0 0
Totale 447